¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ÇÑÀÇ¿ø °ÆÁ¤³¡

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø, #¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø, #Áú¿°¾ÇÃë, #¼ÛµµÁú¿°¾ÇÃë, #»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø, #Áú¿°¾ÇÃëÇÑÀÇ¿ø, #¼ÛµµÁú¿°¾ÇÃë, #¿¬¼öµ¿»ý¸®ÅëÇÑÀÇ¿ø ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø,,¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø,,Áú¿°¾ÇÃë,,¼ÛµµÁú¿°¾ÇÃë,,»ý¸®ÅëÇÑÀÇ¿øÇÑÀÇ¿ø,,Áú¿°¾ÇÃëÇÑÀÇ¿ø,,¼ÛµµÁú¿°¾ÇÃë,,¿¬¼öµ¿»ý¸®ÅëÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ¿¬¼öµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ¿¬¼öµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÁú¿°¾ÇÃë, ¸¸¼ºÁú¿°, Æ®¸®Äڸ𳪽ºÁú¿°, ³­ÀÓ, °è·ùÀ¯»ê, Áú°ÇÁ¶Áõ, °í¿î¸¾Ä«µå»ç¿ëÇÑÀÇ¿ø, »ý¸®ºÒ¼ø»ý¸®Åë, À¯»êÈĺ¸¾à, ¿°Áõ¼ºÁú¿°, Æó°æ±âÁõ»ó, ½ÃÇè°üÂø»ó, ÀӽżҾçÁõ, ºÒÀÓÇÑÀÇ¿ø, »ý¸®ÅëÄ¡·á, »ý¸®ÀüÁõ»ó, ÀÓ½ÅÇѾà, ºÒÀÓÁõ, pms, »ý¸®ÅëÄ¡·á, »ý¸®ÁßµÎÅë, ºÒÀÓÇѹæÄ¡·á, ¼ÒÆļö¼úÈĸöÁ¶¸®, È­ÇÐÀûÀ¯»êÈÄ»ý¸®, ºÒ±ÔÄ¢ÇÑ»ý¸®µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ÀÌ°­·¹ÀÌÀú, ¿äÃß°ßÀÎÄ¡·á, µÎ°³°æÃßÃß³ª, ºñ¸¸Ã³¹æ, ¹úµ¶, °ñµµ¹ý°Ë»ç, ÃÊÀ½ÆĽɺο­Ä¡·á, ±³Á¤Ãß³ª, ÀüÀÚ¿ä¹ý, ±â´ÉÀûÀü±âÀÚ±ØÄ¡·á, ÀåħÀü±âÀڱؼú, ±Ý¿¬Ä§, NMES, Àιٵð°Ë»ç, ³ì¿ë, ¹Ì¿ëħ¼ú, ¸¶»çÁö, traction, ¹°¸®Ä¡·á, manipulation, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀ̸ç Àü³² ´ã¾ç±º ´ëÀü¸é, °æ³² ¾ç»ê½Ã ÇϺϸé, °æ³² â¿ø½Ã ÀÇⱸ ¼Ò°èµ¿, ºÎ»ê Áß±¸ â¼±µ¿1°¡, ÀÎõ Áß±¸ Çؾȵ¿1°¡, °æ±â ¾È¼º½Ã ´ç¿Õµ¿, Ãæ³² ¼­»ê½Ã ¿¹Ãµµ¿, °æ±â ±ºÆ÷½Ã ±ÝÁ¤µ¿, ÃæºÏ ¿Áõ±º ¾È³»¸é, ºÎ»ê µ¿±¸ ¼öÁ¤2µ¿, °­¿ø °­¸ª½Ã Ãʴ絿, °æ³² â¿ø½Ã ÁøÇر¸ Ź鵿, °æ³² ÇԾȱº »êÀθé, Àü³² È­¼ø±º È­¼øÀ¾, °­¿ø ¼ÓÃʽà ûȣµ¿, ¼¼Á¾ Àüµ¿¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãᵿ, ¿ï»ê ºÏ±¸ âÆòµ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æºÏ ¾Èµ¿½Ã ºÏÈĸé, ºÎ»ê ¿µµµ±¸ ûÇÐ1µ¿, ÀÎõ ³²µ¿±¸ ³²Ã̵¿, ÀÎõ Áß±¸ Ç×µ¿3°¡, ÀüºÏ ¼øⱺ Àΰè¸é, ºÎ»ê Áß±¸ Áß¾Óµ¿7°¡, ÀüºÏ ÀӽDZº ÀÓ½ÇÀ¾, °æºÏ ¿µÁֽà °¡Èﵿ, °æ³² â¿ø½Ã ÁøÇر¸ Ã湫µ¿, ÀüºÏ ¼øⱺ À¯µî¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãá3µ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â ¸¶µµ¸é, ÀÛÀüµ¿, Áßµ¿, ÇÐÀ͵¿, »óµ¿, µµÈ­µ¿, ¼±Çе¿, ³²¾çÀ¾, ¼Û¸²µ¿, ûÇе¿, ¿ëÇöµ¿, °Ë¾Ï, ¹®Çе¿, ³²±¸, Á¤¿Õµ¿, ½ÃÈ­, ºñºÀ¸é, ÀÎõ, ½ÃÈï, ¼­Ã¢µ¿, °è»êµ¿, ¿¬¼öµ¿, µ¿ÀÎõ, ¿¬¼ö±¸, ¼Ûµµ½Åµµ½Ã, ¿î¼­µ¿, ÀÎõ³íÇö, ¼®³²µ¿, µµ¸²µ¿, ¼Û»ê¸é, ¸¸¼öµ¿, °£¼®µ¿, ¸Å¼Û¸é, °è¾ç±¸, µ¿±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017; 215:220. 2. Glanc P, Benacerraf B, Bourne T, et al. First International Consensus Report on Adnexal Masses: Management Recommendations. J Ultrasound Med 2017; 36:849. 3. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85:139. 4. Facchinetti F, Sgarbi L, Piccinini F, Volpe A. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial. Gynecol Endocrinol 2002; 16:39. 5. Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 2004; 82 Suppl 1:S228. 6. Pasquali R, Gambineri A, Cavazza C, et al. Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. Eur J Endocrinol 2011; 164:53. 7. Minaglia S, Mishell DR Jr, Ballard CA. Incisional endometriomas after Cesarean section: a case series. J Reprod Med 2007; 52:630. 8. Mascarenhas MN, Flaxman SR, Boerma T, et al. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 2012; 9:e1001356. 9. Vercellini P, Somigliana E, Consonni D, et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. Hum Reprod 2012; 27:3450.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼Ûµµ»ý¸®ÅëÇÑÀÇ¿ø ÇÑÀÇ¿ø °ÆÁ¤³¡""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÇÑÆ÷Áø ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
´ÙÀ½±Û ÀÎõ±¸¾È¿Í»ç ÇÑÀÇ¿ø ȸº¹À§ÇØ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
772 ±¤ÁÖ ¿Ã¹Ù¸¥ÇÑÀÇ¿ø »ó¹«Áö±¸ ´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¼öÇè»ý ÇÒÀÎ À̺¥Æ® 0 1,908 2020-12-01
771 ¸®»ùÇÑÀÇ¿ø ÀÏ»êÁ¡ 2020³â 12¿ù À̺¥Æ® ¾È³» 0 1,055 2020-12-01
770 ÇØÀ²ÇÑÀÇ¿ø ÀÎõÁ¡ 12¿ù À̺¥Æ® 0 1,546 2020-12-01
769 ÀÌõ ±³Åë»ç°í ÀÔ¿ø º´¿ø ¹Ì¿ÃÇÑÀÇ¿ø ÀÔ¿ø½Ç ¾Ë·Áµå·Á¿ä 6 1,724 2020-11-28
768 ¼öÇè»ýº¸¾à, ¼öÇè»ý ´ÙÀ̾îÆ® À̺¥Æ®: ¼ö´ÉÀÇ ½ÃÀÛ°ú ³¡Àº ¼ø¸®ÇÑÀÇ¿ø.. 0 4,120 2020-11-27
767 ½º¸¶Æ®ÇÑÀÇ¿ø 12¿ù À̺¥Æ® 0 805 2020-11-25
766 ¾î±úµ¿¹«ÇÑÀÇ¿ø 11¿ù µ¿Çà À̺¥Æ® 0 1,020 2020-11-18
765 ·Î´ãÇÑÀÇ¿ø 11¿ù À̺¥Æ® 2źÀÔ´Ï´Ù 0 1,496 2020-11-12
764 [Àå¼ö´çÇÑÀÇ¿ø] ÀÌÀü°³¿ø ±â³ä À̺¥Æ® ¾È³» 0 1,657 2020-11-12
763 ÀºÇ೪¹«ÇÑÀÇ¿ø 2020³â 11¿ù ¼ö´É À̺¥Æ® 0 922 2020-11-09
762 2020³â<¾î±úµ¿¹« ÇÑÀÇ¿ø> ¼ö´É, µ¿ÇàÀ̺¥Æ® 0 1,003 2020-11-09
761 ·Î´ãÇÑÀÇ¿ø 11¿ù À̺¥Æ® ¾È³»ÀÔ´Ï´Ù 0 1,362 2020-11-09
760 ³» ¸é¿ª¼¼Æ÷ 70%°¡ Àå¿¡ ºÐÆ÷ ..º¯ºñ°¡ ¾ø¾îÁ³³×¿ä 0 662 2020-11-06
759 ±¤ÁÖ±Ô¸²ÇÑÀÇ¿ø 2020³â 11¿ù~12¿ù À̺¥Æ® ÀÔ´Ï´Ù 0 1,373 2020-11-04
758 11¿ù ÂüÇÑÀÇ¿ø ¸é¿ª·Â °­È­¿¡ ÁÁÀº °æ¿Á°í, °æ¿Áȯ ÇÒÀÎ À̺¥Æ® 0 826 2020-11-04
757 [11¿ù]¼öÇÑÀÇ¿ø ÃѸí°øÁø´Ü À̺¥Æ® 0 856 2020-11-04
756 ´Ù³ªÇÑÀÇ¿øÀÇ 11¿ù ȯÀý±â À̺¥Æ® 0 830 2020-11-04
755 ÇØÀ²ÇÑÀÇ¿ø È«´ëÁ¡ 2020³â 11¿ù °¡°Ý À̺¥Æ® ¾È³» 0 1,417 2020-11-04
754 ¿¬¸»Áغñ ±Ô¸²ÇÑÀÇ¿ø°ú ÇÔ²² Çϼ¼¿ä 0 912 2020-10-29
753 [µµºÀ°æÈñÇÑÀÇ¿ø] 10¿ù ÇÒÀÎ À̺¥Æ® 0 1,143 2020-10-12
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷